(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.
Fig. 3. Status of downstream signaling intermediates in HDFs expressing the different E5 proteins. (A, upper panel of B) Whole-cell extracts of proliferating HDFs expressing the indicated E5 protein, v-Sis or no viral oncoprotein (control) were subjected to immunoblotting. In A, blots were probed with antibodies specific for phosphorylated (p) forms of JNK, AKT, ERK1/2 or c-Jun, and then stripped and reprobed with pan-specific antibodies detecting the total amount of each protein. JNK isoforms 1 and 2 are indicated on the right. In B (upper panel) the blot was probed with a cyclin D3-specific antibody and then reprobed with actin antibodies. In B (lower panel) E5-expressing HDFs were either untreated (–) or treated with of 20 µM LY294002 (LY) or 310 nM wortmannin (W) for 24 hours. Whole-cell lysates were prepared and immunoblotted for cyclin D3 and β-tubulin.
